INJECTION SITE PANNICULITIS

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting INJECTION SITE PANNICULITIS:

# Drug Count
0 INTERFERON BETA-1A 4
1 CABOTEGRAVIR SODIUM 2
2 RILPIVIRINE 2
3 ALPRAZOLAM 1
4 DENOSUMAB 1
5 FOSCARBIDOPA/FOSLEVODOPA 1
6 FULVESTRANT 1
7 GOSERELIN 1
8 ONABOTULINUMTOXINA 1
9 PALBOCICLIB 1
See all common drugs associated with INJECTION SITE PANNICULITIS

INJECTION SITE PANNICULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CABOTEGRAVIR SODIUM 2 0.0012
1 RILPIVIRINE 2 0.0003
2 FOSCARBIDOPA/FOSLEVODOPA 1 0.0001
3 GOSERELIN 1 0.0001
4 FULVESTRANT 1 0.0000
5 PAROXETINE HYDROCHLORIDE 1 0.0000
6 INTERFERON BETA-1A 4 0.0000
7 ONABOTULINUMTOXINA 1 0.0000
8 PALBOCICLIB 1 0.0000
9 DENOSUMAB 1 0.0000
See all drugs enriched for association with INJECTION SITE PANNICULITIS

INJECTION SITE PANNICULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 1 0.0000
1 Interferon beta [EPC] 4 0.0000
2 Acetylcholine Release Inhibitor [EPC] 1 0.0000
3 RANK Ligand Inhibitor [EPC] 1 0.0000
4 Kinase Inhibitor [EPC] 1 0.0000
5 Benzodiazepine [EPC] 1 0.0000
See all drug classes enriched for association with INJECTION SITE PANNICULITIS